Furthermore, c-MYC potentially enhances the activation of SIRT1 by directly binding to the SIRT1 inhibitor Deleted in Breast Cancer 1 (DBC1) and blocking its interaction with SIRT1. The gene discussed is MYC; the disease is cancer.